INVESTOR REMINDER: Berger Montague Notifies Ultragenyx Pharmaceutical Inc. (RARE) Investors of a Class Action Lawsuit and Deadline
Ultragenyx Pharmaceutical(US:RARE) TMX Newsfile·2026-03-09 15:06Philadelphia, Pennsylvania--(Newsfile Corp. - March 9, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) ("Ultragenyx" or the "Company") on behalf of investors who purchased Ultragenyx common stock during the period from August 3, 2023 through December 26, 2025 (the "Class Period").Investor Deadline: Investors who purchased Ultragenyx common stock during the Class Period may, no later than Apri ...